Natera [NTRA] vs Iqvia Holdings [IQV] Detailed Stock Comparison

Natera

Iqvia Holdings
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Natera wins in 5 metrics, Iqvia Holdings wins in 13 metrics, with 0 ties. Iqvia Holdings appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Natera | Iqvia Holdings | Better |
---|---|---|---|
P/E Ratio (TTM) | -109.73 | 29.90 | Natera |
Price-to-Book Ratio | 18.37 | 6.08 | Iqvia Holdings |
Debt-to-Equity Ratio | 15.74 | 272.12 | Natera |
PEG Ratio | -0.75 | -1.35 | Iqvia Holdings |
EV/EBITDA | -84.52 | 16.66 | Natera |
Profit Margin (TTM) | -12.89% | 7.88% | Iqvia Holdings |
Operating Margin (TTM) | -20.19% | 13.39% | Iqvia Holdings |
EBITDA Margin (TTM) | N/A | 13.39% | N/A |
Return on Equity | -24.32% | 19.79% | Iqvia Holdings |
Return on Assets (TTM) | -11.21% | 5.16% | Iqvia Holdings |
Free Cash Flow (TTM) | $58.75M | $2.11B | Iqvia Holdings |
1-Year Return | 28.89% | -10.57% | Natera |
Price-to-Sales Ratio (TTM) | 11.69 | 2.24 | Iqvia Holdings |
Enterprise Value | $22.15B | $48.69B | Iqvia Holdings |
EV/Revenue Ratio | 11.28 | 3.10 | Iqvia Holdings |
Gross Profit Margin (TTM) | 63.41% | 32.94% | Natera |
Revenue per Share (TTM) | $15 | $89 | Iqvia Holdings |
Earnings per Share (Diluted) | $-1.91 | $6.91 | Iqvia Holdings |
Beta (Stock Volatility) | 1.74 | 1.33 | Iqvia Holdings |
Natera vs Iqvia Holdings Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Natera | 0.51% | 2.69% | -0.11% | 3.46% | 20.65% | 4.20% |
Iqvia Holdings | -0.78% | 13.45% | 9.24% | 26.20% | 33.99% | 5.07% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Natera | 28.89% | 291.28% | 127.44% | 1,665.30% | 829.72% | 829.72% |
Iqvia Holdings | -10.57% | 18.23% | 24.59% | 186.46% | 383.65% | 383.65% |
News Based Sentiment: Natera vs Iqvia Holdings
Natera
News based Sentiment: MIXED
Natera reported a revenue beat but an EPS miss, showcasing a classic growth company dynamic. Positive clinical trial enrollment and validation data are offset by insider selling and mixed institutional activity, creating a balanced, albeit complex, investment picture.
Iqvia Holdings
News based Sentiment: POSITIVE
IQVIA delivered a strong Q2 performance, raised its full-year guidance, and saw increased analyst and institutional confidence. While insider selling is a minor concern, the overall narrative for the month is positive, suggesting continued growth and investment potential.
Performance & Financial Health Analysis: Natera vs Iqvia Holdings
Metric | NTRA | IQV |
---|---|---|
Market Information | ||
Market Cap | $22.97B | $36.03B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 1,304,230 | 1,417,620 |
90 Day Avg. Volume | 1,056,837 | 1,292,383 |
Last Close | $171.86 | $205.02 |
52 Week Range | $92.14 - $183.00 | $134.65 - $237.34 |
% from 52W High | -6.09% | -13.62% |
All-Time High | $183.00 (Jan 13, 2025) | $285.61 (Dec 27, 2021) |
% from All-Time High | -6.09% | -28.22% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.32% | 0.05% |
Quarterly Earnings Growth | N/A | -0.27% |
Financial Health | ||
Profit Margin (TTM) | -0.13% | 0.08% |
Operating Margin (TTM) | -0.20% | 0.13% |
Return on Equity (TTM) | -0.24% | 0.20% |
Debt to Equity (MRQ) | 15.74 | 272.12 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $9.11 | $33.99 |
Cash per Share (MRQ) | $7.40 | $12.87 |
Operating Cash Flow (TTM) | $186.70M | $2.62B |
Levered Free Cash Flow (TTM) | $149.53M | $2.45B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Natera vs Iqvia Holdings
Metric | NTRA | IQV |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -109.73 | 29.90 |
Forward P/E | -138.31 | 17.12 |
PEG Ratio | -0.75 | -1.35 |
Price to Sales (TTM) | 11.69 | 2.24 |
Price to Book (MRQ) | 18.37 | 6.08 |
Market Capitalization | ||
Market Capitalization | $22.97B | $36.03B |
Enterprise Value | $22.15B | $48.69B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 11.28 | 3.10 |
Enterprise to EBITDA | -84.52 | 16.66 |
Risk & Other Metrics | ||
Beta | 1.74 | 1.33 |
Book Value per Share (MRQ) | $9.11 | $33.99 |
Financial Statements Comparison: Natera vs Iqvia Holdings
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | NTRA | IQV |
---|---|---|
Revenue/Sales | $546.60M | $4.02B |
Cost of Goods Sold | $200.00M | $2.69B |
Gross Profit | $346.60M | $1.32B |
Research & Development | $146.43M | N/A |
Operating Income (EBIT) | $-110.37M | $538.00M |
EBITDA | $-89.78M | $813.00M |
Pre-Tax Income | $-100.66M | $323.00M |
Income Tax | $275,000 | $56.00M |
Net Income (Profit) | $-100.94M | $266.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | NTRA | IQV |
---|---|---|
Cash & Equivalents | $973.77M | $2.04B |
Total Current Assets | $1.42B | $6.35B |
Total Current Liabilities | $365.68M | $7.57B |
Long-Term Debt | $103.06M | $14.39B |
Total Shareholders Equity | $1.24B | $5.79B |
Retained Earnings | $-2.63B | $6.58B |
Property, Plant & Equipment | $94.63M | $816.00M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | NTRA | IQV |
---|---|---|
Operating Cash Flow | $12.99M | $459.00M |
Capital Expenditures | $-21.82M | $-151.00M |
Free Cash Flow | $22.64M | $292.00M |
Debt Repayment | N/A | $-1.74B |
Common Stock Repurchase | N/A | $-657.00M |
Short Interest & Institutional Ownership Analysis
Metric | NTRA | IQV |
---|---|---|
Shares Short | 3.79M | 4.68M |
Short Ratio | 3.75 | 3.92 |
Short % of Float | 0.03% | 0.03% |
Average Daily Volume (10 Day) | 1,304,230 | 1,417,620 |
Average Daily Volume (90 Day) | 1,056,837 | 1,292,383 |
Shares Outstanding | 132.65M | 176.10M |
Float Shares | 132.93M | 161.46M |
% Held by Insiders | 0.03% | 0.01% |
% Held by Institutions | 0.96% | 1.02% |
Dividend Analysis & Yield Comparison: Natera vs Iqvia Holdings
Metric | NTRA | IQV |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |